Basics HilleVax, Inc. IPO Date: April 29, 2022 Sector: Healthcare Industry: Biotech Market Cap: $104.76M Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 3.06% Avg Daily Range (30 D): $0.00 | 0.16% Avg Daily Range (90 D): $0.03 | 1.38% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .11M Avg Daily Volume (90 D): .41M Trade Size Avg Trade Size (Sh.): 124 Avg Trade Size (Sh.) (30 D): 615 Avg Trade Size (Sh.) (90 D): 439 Institutional Trades Total Inst.Trades: 122 Avg Inst. Trade: $1.84M Avg Inst. Trade (30 D): $2.33M Avg Inst. Trade (90 D): $1.6M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.72M Avg Closing Trade (30 D): $4.12M Avg Closing Trade (90 D): $4.89M Avg Closing Volume: 318.71K     News Sep 17, 2025 @ 1:00 PM XOMA Royalty Announces Closing of Tender Offer for... Source: Xoma Royalty Corporation Aug 4, 2025 @ 11:00 AM HilleVax Enters into a Definitive Agreement to be ... Source: Not Specified Jul 19, 2024 @ 3:02 PM HilleVax, Inc. (HLVX) Investigation: Bronstein, Ge... Source: Bronstein, Gewirtz & Grossman, Llc Jul 14, 2024 @ 3:01 PM HilleVax, Inc. (HLVX) Investigation: Bronstein, Ge... Source: Bronstein, Gewirtz & Grossman, Llc Jul 9, 2024 @ 8:45 PM (HLVX) - Analyzing HilleVax's Short Interest - Hil... Source: Benzinga Insights, Benzinga Staff Writer Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.11 $-.12 $-.69 Diluted EPS $-.11 $-.12 $-.69 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -5.27M $ -6.06M $ -33.95M Operating Income / Loss $ -6.99M $ -7.6M $ -36.15M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ 50.7M PE Ratio